New York Assembly Bill 2650: Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.

New York · 2025-2026 session

What it does

Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.

Latest action

referred to insurance (2026-01-07)

See how A 2650 affects you on CapitolKey

Browse more bills · CapitolKey home